Yael Margolin - 01 Jan 2023 Form 3/A - Amendment Insider Report for BiondVax Pharmaceuticals Ltd. (SCNI)

Role: Director
Signature: /s/ Yael Margolin
Issuer symbol: SCNI
Transactions as of: 01 Jan 2023
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 23 Jan 2023, 07:16:22 UTC
Date Of Original Report: 03 Jan 2023
Previous filing: 23 Nov 2022
Next filing: 05 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BVXV	Ordinary Shares						66,800	01 Jan 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BVXV	Stock Options (right to buy)							01 Jan 2023	Ordinary Shares	720,000	$0.1820	Direct	F1, F2
holding	BVXV	Stock Options (right to buy)							01 Jan 2023	Ordinary Shares	1,000,000	$0.1740	Direct	F2, F3
holding	BVXV	Restricted Share Units							01 Jan 2023	Ordinary Shares	133,200		Direct	F2, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock options were granted on March 24, 2020 and are fully vested.
F2	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents four hundred Ordinary Shares.
F3	Stock options were granted on April 6, 2021 and vest on a monthly basis during a period of three years.
F4	Restricted share units were granted on April 6, 2021 and vest on a monthly basis during a period of three years.
F5	Each restricted share unit represents a contingent right to receive one ordinary share.